Baxter EBITDA 2012-2025 | BAX
Baxter annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Baxter EBITDA for the quarter ending September 30, 2025 was $409M, a 0% increase year-over-year.
- Baxter EBITDA for the twelve months ending September 30, 2025 was $1.447B, a 23.07% decline year-over-year.
- Baxter 2024 annual EBITDA was $1.486B, a 12.12% decline from 2023.
- Baxter 2023 annual EBITDA was $1.691B, a 22.27% increase from 2022.
- Baxter 2022 annual EBITDA was $1.383B, a 37.62% decline from 2021.
|
Baxter Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,486 |
| 2023 | $1,691 |
| 2022 | $1,383 |
| 2021 | $2,217 |
| 2020 | $2,456 |
| 2019 | $2,592 |
| 2018 | $2,355 |
| 2017 | $2,038 |
| 2016 | $1,545 |
| 2015 | $1,208 |
| 2014 | $1,448 |
| 2013 | $1,131 |
| 2012 | $3,482 |
| 2011 | $3,616 |
|
Baxter Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $409 |
| 2025-06-30 | $448 |
| 2025-03-31 | $305 |
| 2024-12-31 | $285 |
| 2024-09-30 | $409 |
| 2024-06-30 | $406 |
| 2024-03-31 | $386 |
| 2023-12-31 | $680 |
| 2023-09-30 | $271 |
| 2023-06-30 | $298 |
| 2023-03-31 | $442 |
| 2022-12-31 | $-335 |
| 2022-09-30 | $568 |
| 2022-06-30 | $607 |
| 2022-03-31 | $543 |
| 2021-12-31 | $245 |
| 2021-09-30 | $719 |
| 2021-06-30 | $646 |
| 2021-03-31 | $607 |
| 2020-12-31 | $619 |
| 2020-09-30 | $679 |
| 2020-06-30 | $550 |
| 2020-03-31 | $608 |
| 2019-12-31 | $745 |
| 2019-09-30 | $698 |
| 2019-06-30 | $574 |
| 2019-03-31 | $575 |
| 2018-12-31 | $571 |
| 2018-09-30 | $581 |
| 2018-06-30 | $579 |
| 2018-03-31 | $624 |
| 2017-12-31 | $476 |
| 2017-09-30 | $484 |
| 2017-06-30 | $531 |
| 2017-03-31 | $547 |
| 2016-12-31 | $504 |
| 2016-09-30 | $390 |
| 2016-06-30 | $274 |
| 2016-03-31 | $377 |
| 2015-12-31 | $344 |
| 2015-09-30 | $308 |
| 2015-06-30 | $277 |
| 2015-03-31 | $279 |
| 2014-12-31 | $391 |
| 2014-09-30 | $320 |
| 2014-06-30 | $912 |
| 2014-03-31 | $908 |
| 2013-12-31 | $608 |
| 2013-09-30 | $861 |
| 2013-06-30 | $1,011 |
| 2013-03-31 | $898 |
| 2012-12-31 | $701 |
| 2012-09-30 | $956 |
| 2012-06-30 | $957 |
| 2012-03-31 | $868 |
| 2011-12-31 | $792 |
| 2011-09-30 | $921 |
| 2011-06-30 | $1,000 |
| 2011-03-31 | $903 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.317B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.859B | 21.09 |
| EssilorLuxottica (ESLOY) | France | $145.490B | 0.00 |
| Stryker (SYK) | United States | $137.164B | 27.23 |
| Boston Scientific (BSX) | United States | $135.332B | 30.95 |
| Medtronic (MDT) | Ireland | $129.919B | 18.00 |
| Medline (MDLN) | United States | $60.378B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.195B | 0.00 |
| Agilent Technologies (A) | United States | $39.301B | 24.84 |
| GE HealthCare Technologies (GEHC) | United States | $37.303B | 17.84 |
| ResMed (RMD) | United States | $37.266B | 25.79 |
| Koninklijke Philips (PHG) | Netherlands | $28.637B | 18.70 |
| Terumo (TRUMY) | Japan | $20.358B | 22.92 |
| Insulet (PODD) | United States | $19.697B | 61.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.349B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.055B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.233B | 29.60 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.455B | 13.57 |
| BillionToOne (BLLN) | United States | $4.145B | 0.00 |
| Envista Holdings (NVST) | United States | $4.014B | 23.03 |
| ICU Medical (ICUI) | United States | $3.914B | 24.85 |
| Haemonetics (HAE) | United States | $3.278B | 14.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.257B | 14.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.159B | 47.26 |
| QuidelOrtho (QDEL) | United States | $2.076B | 13.35 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $1.990B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.945B | 39.15 |
| Curaleaf Holdings (CURLF) | Canada | $1.764B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.687B | 16.85 |
| Green Thumb Industries (GTBIF) | United States | $1.649B | 72.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.442B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.422B | 20.59 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.390B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.251B | 371.14 |
| Capricor Therapeutics (CAPR) | United States | $1.105B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.064B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.890B | 10.06 |
| Valneva SE (VALN) | France | $0.886B | 0.00 |
| Omeros (OMER) | United States | $0.861B | 0.00 |
| CeriBell (CBLL) | United States | $0.842B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.602B | 16.32 |
| Verano Holdings (VRNO) | United States | $0.516B | 0.00 |
| Cerus (CERS) | United States | $0.503B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.431B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.337B | 0.00 |
| Evolus (EOLS) | United States | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.282B | 22.51 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 144.33 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.235B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.199B | 17.54 |
| Sanara MedTech (SMTI) | United States | $0.198B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.195B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.183B | 0.00 |
| Accendra Health (ACH) | United States | $0.163B | 1.64 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.132B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.56 |
| Sharps Technology (STSS) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.23 |
| Nephros (NEPH) | United States | $0.050B | 35.85 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.27 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |